ZA200703244B - Halogen substituted benzodiazepine derivatives - Google Patents
Halogen substituted benzodiazepine derivativesInfo
- Publication number
- ZA200703244B ZA200703244B ZA200703244A ZA200703244A ZA200703244B ZA 200703244 B ZA200703244 B ZA 200703244B ZA 200703244 A ZA200703244 A ZA 200703244A ZA 200703244 A ZA200703244 A ZA 200703244A ZA 200703244 B ZA200703244 B ZA 200703244B
- Authority
- ZA
- South Africa
- Prior art keywords
- halogen substituted
- benzodiazepine derivatives
- substituted benzodiazepine
- derivatives
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04105167 | 2004-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200703244B true ZA200703244B (en) | 2008-08-27 |
Family
ID=35735152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200703244A ZA200703244B (en) | 2004-10-20 | 2007-04-19 | Halogen substituted benzodiazepine derivatives |
Country Status (17)
Country | Link |
---|---|
US (1) | US7507728B2 (no) |
EP (1) | EP1807432A1 (no) |
JP (1) | JP4751398B2 (no) |
KR (1) | KR100915469B1 (no) |
CN (1) | CN101084220B (no) |
AR (1) | AR051333A1 (no) |
AU (1) | AU2005299031B2 (no) |
BR (1) | BRPI0516244A (no) |
CA (1) | CA2584757C (no) |
IL (1) | IL182697A (no) |
MX (1) | MX2007004640A (no) |
NO (1) | NO20072046L (no) |
NZ (1) | NZ554556A (no) |
RU (1) | RU2007114763A (no) |
TW (1) | TWI304404B (no) |
WO (1) | WO2006045429A1 (no) |
ZA (1) | ZA200703244B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4885967B2 (ja) * | 2005-10-11 | 2012-02-29 | エフ.ホフマン−ラ ロシュ アーゲー | イミダゾベンゾジアゼピン誘導体 |
RU2563167C2 (ru) * | 2010-11-05 | 2015-09-20 | Ф. Хоффманн-Ля Рош Аг | Применение активных фармацевтических соединений для лечения заболеваний центральной нервной системы |
EP2457569A1 (en) | 2010-11-05 | 2012-05-30 | F. Hoffmann-La Roche AG | Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
MX2016007808A (es) * | 2013-12-20 | 2016-09-07 | Agenebio Inc | Derivados de benzodiazepina, composiciones, y metodos para tratar el deterioro congnitivo. |
CA2990004C (en) | 2015-06-19 | 2024-04-23 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
BR112019012821A2 (pt) | 2016-12-19 | 2019-11-26 | Agenebio Inc | derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo |
US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
IL272652B (en) * | 2017-09-07 | 2022-09-01 | Eisai R&D Man Co Ltd | A pentacyclic compound, the pharmaceutical compounds that make it up and their use for the treatment of Alzheimer's disease |
MX2020013927A (es) | 2018-06-19 | 2021-03-02 | Agenebio Inc | Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo. |
EP3936189A4 (en) | 2019-03-05 | 2022-12-14 | Eisai R&D Management Co., Ltd. | SALT OF A PENTACYCLIC COMPOUND AND CRYSTALS THEREOF |
AU2020232044A1 (en) | 2019-03-05 | 2021-09-02 | Eisai R&D Management Co., Ltd. | Pentacyclic heterocyclic compound |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ180218A (en) * | 1975-08-07 | 1983-07-15 | Hoffmann La Roche | 6-(phenyl or pyridyl)-4h-imidazo(1,5-a) (1,4) diazepines |
CA1143728A (en) | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
CA1174673A (en) * | 1981-02-27 | 1984-09-18 | Walter Hunkeler | Imidazodiazepines |
CA1252462A (en) | 1984-01-19 | 1989-04-11 | Walter Hunkeler | Imidazodiazepine derivatives |
DK174086D0 (da) | 1986-04-16 | 1986-04-16 | Ferrosan As | Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme |
US4897392A (en) | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
TW201311B (no) * | 1991-06-17 | 1993-03-01 | Hoffmann La Roche | |
JPH078869A (ja) * | 1993-06-29 | 1995-01-13 | Mitsubishi Chem Corp | 粉粒体のコーティング方法 |
TWI239333B (en) * | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
US6686352B2 (en) * | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
-
2005
- 2005-10-11 JP JP2007537161A patent/JP4751398B2/ja not_active Expired - Fee Related
- 2005-10-11 NZ NZ554556A patent/NZ554556A/en not_active IP Right Cessation
- 2005-10-11 BR BRPI0516244-0A patent/BRPI0516244A/pt not_active IP Right Cessation
- 2005-10-11 WO PCT/EP2005/010907 patent/WO2006045429A1/en active Application Filing
- 2005-10-11 RU RU2007114763/04A patent/RU2007114763A/ru not_active Application Discontinuation
- 2005-10-11 CN CN2005800437012A patent/CN101084220B/zh not_active Expired - Fee Related
- 2005-10-11 MX MX2007004640A patent/MX2007004640A/es active IP Right Grant
- 2005-10-11 KR KR1020077011333A patent/KR100915469B1/ko not_active IP Right Cessation
- 2005-10-11 AU AU2005299031A patent/AU2005299031B2/en not_active Ceased
- 2005-10-11 CA CA2584757A patent/CA2584757C/en not_active Expired - Fee Related
- 2005-10-11 EP EP05794805A patent/EP1807432A1/en not_active Withdrawn
- 2005-10-17 US US11/252,026 patent/US7507728B2/en not_active Expired - Fee Related
- 2005-10-17 TW TW094136186A patent/TWI304404B/zh not_active IP Right Cessation
- 2005-10-18 AR ARP050104347A patent/AR051333A1/es unknown
-
2007
- 2007-04-19 IL IL182697A patent/IL182697A/en not_active IP Right Cessation
- 2007-04-19 ZA ZA200703244A patent/ZA200703244B/xx unknown
- 2007-04-20 NO NO20072046A patent/NO20072046L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101084220A (zh) | 2007-12-05 |
US7507728B2 (en) | 2009-03-24 |
AU2005299031A1 (en) | 2006-05-04 |
CA2584757C (en) | 2012-07-03 |
BRPI0516244A (pt) | 2008-08-26 |
WO2006045429A1 (en) | 2006-05-04 |
TWI304404B (en) | 2008-12-21 |
IL182697A (en) | 2012-02-29 |
KR100915469B1 (ko) | 2009-09-03 |
RU2007114763A (ru) | 2008-11-27 |
TW200630371A (en) | 2006-09-01 |
EP1807432A1 (en) | 2007-07-18 |
CA2584757A1 (en) | 2006-05-04 |
US20060084801A1 (en) | 2006-04-20 |
AR051333A1 (es) | 2007-01-03 |
AU2005299031B2 (en) | 2011-11-10 |
JP2008517010A (ja) | 2008-05-22 |
NZ554556A (en) | 2009-11-27 |
CN101084220B (zh) | 2010-12-15 |
NO20072046L (no) | 2007-04-26 |
KR20070085398A (ko) | 2007-08-27 |
MX2007004640A (es) | 2007-06-08 |
IL182697A0 (en) | 2007-09-20 |
JP4751398B2 (ja) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182697A0 (en) | Halogen substituted benzodiazepine derivatives | |
TWI369356B (en) | Tetrahydropyridoindole derivatives | |
IL180481A0 (en) | Aryl-pyridine derivatives | |
ZA200702479B (en) | 4-heteroarylmethyl substituted phthalazinone derivatives | |
HK1105971A1 (en) | Pyrrazolo-pyrimidine derivatives | |
IL181408A0 (en) | 4-heteroarylmethyl substituted phthalazinone derivatives | |
AP2074A (en) | New 4-benzylidene-piperidin derivatives | |
IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
IL182585A0 (en) | Imidazo-benzodiazepine derivatives | |
IL183594A0 (en) | Phenyl-piperazin methanone derivatives | |
HK1101638A1 (en) | New pyridothienopyrimidine derivatives | |
HK1100002A1 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
IL183141A0 (en) | New pyridothienopyrimidine derivatives | |
HK1100775A1 (en) | 4-Amino-5-cyanopyrimidine derivatives | |
GB0414272D0 (en) | OsK1 derivatives | |
HK1096380A1 (zh) | 二環芳基亞磺酰衍生物 | |
IL182001A0 (en) | 2-acylaminothiazole derivatives | |
HU0400338D0 (en) | New substituted benzodiazepine derivatives | |
GB0404801D0 (en) | Bicyclic derivatives | |
GB0405905D0 (en) | Azaquinazoline derivatives | |
GB0422397D0 (en) | 3-Cyano-Quinoline derivatives | |
SI1654253T1 (sl) | Substituirani 3-pirolidin-indolni derivati |